Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC

(MedPage Today) -- A dose-escalation strategy involving hypofractionated concurrent chemoradiation with adaptive stereotactic ablative radiotherapy (SABR) appeared safe and effective for patients with locally advanced non-small cell lung cancer...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news